Mark Baldry
Corporate Officer/Principal chez X4 PHARMACEUTICALS, INC.
Fortune : 27 900 $ au 30/04/2024
Postes actifs de Mark Baldry
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| X4 PHARMACEUTICALS, INC. | Corporate Officer/Principal | 26/11/2022 | - |
Historique de carrière de Mark Baldry
Anciens postes connus de Mark Baldry
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Wave Life Sciences USA, Inc.
 Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Part of Wave Life Sciences Ltd., Wave Life Sciences USA, Inc. is a company that provides nucleic acid therapeutics. The company is based in Cambridge, MA. The company was founded in 2012 by Gregory L. Verdine, Takeshi Wada. The CEO is Paul B. Bolno. | Corporate Officer/Principal | 01/08/2019 | 01/02/2020 |
| AMICUS THERAPEUTICS, INC. | Sales & Marketing | 08/06/2015 | 01/07/2019 |
| BIOGEN INC. | Public Communications Contact | - | 01/05/2015 |
| FREELINE THERAPEUTICS HOLDINGS PLC | Corporate Officer/Principal | 02/11/2020 | - |
| WAVE LIFE SCIENCES LTD. | Corporate Officer/Principal | 06/08/2019 | - |
| SHIRE | Corporate Officer/Principal | - | - |
Formation de Mark Baldry
| Concordia University | Masters Business Admin |
| York University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Canada | 3 |
| Irlande | 2 |
Opérationnelle
| Corporate Officer/Principal | 5 |
| Sales & Marketing | 1 |
| Public Communications Contact | 1 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 3 |
| Utilities | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| AMICUS THERAPEUTICS, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| WAVE LIFE SCIENCES LTD. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Wave Life Sciences USA, Inc.
Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Part of Wave Life Sciences Ltd., Wave Life Sciences USA, Inc. is a company that provides nucleic acid therapeutics. The company is based in Cambridge, MA. The company was founded in 2012 by Gregory L. Verdine, Takeshi Wada. The CEO is Paul B. Bolno. | Utilities |
- Bourse
- Insiders
- Mark Baldry
- Expérience